An increase in collagen-mediated aggregation was observed 3 weeks post drug termination in the crossover study ( 15.4 % vs baseline ; 95 % confidence interval [ CI ] , 3.9-27 .0 ) , which was not observed during the treatment phase and was not observed in the parallel-group study employing a more robust EC50 examination .